Great discussion on OA today at the Plenary session. #ACR19 @RheumNow What would you try in your erosive OA patients who have failed conservative therapy (hand therapy, analgesics and NSAIDs)?

@RheumNow What about pred for hand OA? Well PNL 10 has an effect while you're taking it, with reduction of synovial thickening, and in this study was well tolerated. Stop taking it, and you're back to baseline. Leiden #ACR19 ABST 1760 @RheumNow https://t.co/aw4UNHol7J

Nice data in r-axSpA treated with ixekizumab showing improvements in fatigue, pain and sleep #ACR19 @RheumNow Abs 1510 https://t.co/raBP0Sv5bs

Nice data from @Drbeckyg on patient self joint counts in #rheumatoid. This data supports patients ‘doing it for themselves’ to channel some Eurythmics. #ACR19 @RheumNow Abs 1366 https://t.co/MgFpiDKO7W

So proud of our Chan Mi Lee abstr#1717 comparing brain histopath in PACNS vs other causes of CNS vasculitis. Intramural inflammatory infiltrate more specific than perivascular @RulaHajjAliMD @LCalabreseDO @RheumNow #ACR19 @CleClinicMD #cleclinicrheum https://t.co/CpQH4Ezxzd

Who will win? Elbow Knee, Joint Service Joint Service, or reigning champs Neutrophil Nets! Join us at Knowledge Bowl! @RheumNow #ACR19 https://t.co/IcUN4la4vP

DAAs for Tx of hep C are changing the landscape of mixed cryo- incidence w/HCV steadily decreasing. Abstr#1723 @RheumNow @LCalabreseDO #cleclinicrheum #ACR19 https://t.co/QHDEjxPN7c

Beautiful phase 2 data on a combined uricase and tolerigenic nanoparticle to reduce reactions and maintain irate lowering efficacy over 28 days. Roll on the HTH phase 3 with pegloticase #ACR19 @RheumNow #gout Abs 1235 https://t.co/NnMMgnbPbH

Primary CNS vasculitis is hard to diagnose up front & bx data limited, but maybe reactive astrocytes (being CNS cells) might help differentiate versus mimics? We’ll take all the markers we can get @ClevelandClinic @ChanmiLee @LCalabreseDO @RulaHajjAliMD #ACR19 ABST1717 @RheumNow https://t.co/gF7ayDO6vQ

CZP improves PRO and most importantly sleep in non radio graphic SPAnpatients @RheumNow #ACR19 https://t.co/HfLor8jhSD

#ACR19 @rheumnow Abstr#L09: NORD-STAR trial: DMARD vs biologic 1st line Rx for early RA All got MTX 25mg/wk x1 month then randomized to pred 20mg/taper to 5mg/d in 9 wks v. SSZ 2g bid v. HCQ 35 mg/wk + joint injx v. CZP v. TCZ v. ABT High remiss in all group (best w/ABT)

#ACR19 #rheumtwitter @hausmannMD has a great e-poster this morning on #pedsrheum parental social media use ➡️ Over 700 parents were surveyed, can you guess how many were NOT using social media? @rheumnow @RobShmerling @carrainc @TamarPedsRheum @DrTinyTree https://t.co/SIIpKd5HP8

Looks like giving methotrexate with pegloticase means most can complete their infusion course in uncontrolled #gout. Reduced reactions. MTX to the rescue! #ACR19 @RheumNow Abs 1236 https://t.co/UVE1ov2fno

Checkpoint inhibitors in RA pts: it doesn’t matter why they flare (withdrawal of DMARD etc) - it’s manageable. Don’t deny RA patients potentially life-saving cancer immunotherapy! @sandigursky #ACR19 ABST1339 @RheumNow following @cappelliMD’s call to arms https://t.co/oemBmibcvB

• Laura Cappelli on Twitter: "You heard it from the oncologist- autoimmune d…

#ACR19 @rheumnow ABS1481 Corrona PsA/SpA Registy: real-world use of Apremilast +biologics happens mostly in pts who received prior biologic therapy & pts not able to achieve MDA. otherwise similar characteristics vs those initiating biologic monotherapy and biologic + csDMARDs